Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis |
Multiple Sclerosis | Phase4 | Germany United Kingdom United States |
NCT06444113 |
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies |
Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma | Brazil | NCT05541341 | |
Iptacopan in Patients With ANCA Associated Vasculitis |
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis | Phase2 | China Turkey |
NCT06388941 |
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) |
Hyperlipoproteinemia (a) | Phase3 | Germany | NCT05900141 |
WOE of Anti-CD20 Therapies |
Multiple Sclerosis | United States | NCT06121349 | |
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP) | Phase3 | Argentina Australia Austria Belgium Bulgaria China Czechia France Germany Hong Kong Hungary India Italy Japan Malaysia Mexico Norway Romania Singapore Spain Thailand Turkey United Kingdom United States Vietnam View All |
NCT05653349 |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
Prostate Cancer | Phase4 | Austria Belgium Canada Czechia France Germany Netherlands Spain Sweden United Kingdom United States View All |
NCT05803941 |
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia |
Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase3 | Argentina Australia China France Germany Hungary India Israel Italy Japan Malaysia Romania Singapore Spain Taiwan Thailand United Kingdom United States View All |
NCT05648968 |
Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer |
Non-small Cell Lung Cancer | Phase1 | Germany Japan Korea, Republic of Spain Switzerland United States View All |
NCT05275868 |
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) |
Polymyalgia Rheumatica | Phase3 | Argentina Australia Germany Japan Spain Switzerland United States View All |
NCT06331312 |